1. Antibodies to hepatitis C virus in prospectively followed patients with posttransfusion hepatitis;Lee, S.D.; Hwang, S.J.; Lu, R.H.; Lai, K.H.; Tsai, Y.T.; Lo, K.J.;Jf Infect Dis,1991
2. Clinical course and histological correlations in posttransfusion hepatitis C: the Royal Free Hospital Experience;Patel, A.; Sherlock, S.; Dusheiko, G.; Scheuer, P.; Ellis, L.A.; Ashrafzedeh, P.;Eur Jf Gastroenterol Hepatol,1991
3. Demonstration of viraemia patterns in haemophiliacs treated with hepatitis C virus contaminated factor VIII concentrates;Garson, J.A.; Tuke, P.W.; Makris, M.; Briggs, M.; Machin, S.J.; Preston, F.E.;Lancet,1990
4. Look-back study of infectivity of anti-HCV ELISA-positive blood components;Vrielink, H.; van der Poel, C.L.; Reesink, H.W.; Zaaijer, H.L.; Scholten, E.; Kremer, L.C.M.;Lancet,1995
5. Hepatitis C in asymptomatic British blood donors with indeterminate seropositivity;Mutimer, D.J.; Harrison, R.F.; O'Donnell, K.B.; Shaw, J.; Martin, B.A.B.; Atrah, H.;BMJ,1994